Related Experiment Video

Updated: Jul 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lipid-lowering therapy today: treating the high-risk cardiovascular patient

Kathleen Berra1

  • 1Cardiovascular Medicine and Coronary Interventions, Redwood City, CA 94062, USA. kberra@tlcrns.com

The Journal of Cardiovascular Nursing
|August 30, 2008
PubMed

Insights

Nurse-led case management improves lipid goals for high-risk cardiovascular patients. These programs enhance adherence to lifestyle changes and statin therapy, crucial for preventing heart disease and vascular conditions.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Nursing Research

Background:

  • Cardiovascular diseases are the leading global cause of mortality.
  • Current guidelines recommend intensive low-density lipoprotein cholesterol (LDL-C) reduction for a broader high-risk population.
  • Lifestyle modifications and lipid-lowering drugs are foundational for cardiovascular prevention.

Purpose of the Study:

  • To evaluate the effectiveness of nurse-centered case management in achieving lipid goals.
  • To assess the impact of enhanced adherence support on patient outcomes.
  • To address the gap in LDL-C goal attainment in high-risk individuals.

Main Methods:

  • Implementation of nurse-centered case management programs.
  • Focus on early and sustained adherence to lifestyle modifications.
  • Emphasis on adherence to lipid-lowering drug therapy, including HMG CoA reductase inhibitors (statins).

Main Results:

  • Nurse-centered case management programs demonstrated consistent success in improving lipid goal achievement rates.
  • Enhanced patient support led to better adherence to prescribed therapies.
  • Significant improvements were observed in high-risk patient populations.

Conclusions:

  • Nurse-led interventions are effective in optimizing lipid management for high-risk cardiovascular patients.
  • Case management programs are vital for improving adherence and achieving therapeutic targets.
  • These findings support the integration of nurse-centered care in cardiovascular disease prevention strategies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...